GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Institutional Ownership

Amicogen (XKRX:092040) Institutional Ownership : 4.81% (As of May. 08, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Amicogen's institutional ownership is 4.81%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Amicogen's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Amicogen's Float Percentage Of Total Shares Outstanding is 0.00%.


Amicogen Institutional Ownership Historical Data

The historical data trend for Amicogen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Institutional Ownership Chart

Amicogen Historical Data

The historical data trend for Amicogen can be seen below:

2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30
Institutional Ownership 5.82 5.82 5.09 5.06 5.05 4.85 4.86 4.81 4.83 4.81

Amicogen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Amicogen Business Description

Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.

Amicogen Headlines

No Headlines